Code of Maryland Regulations (Last Updated: April 6, 2021) |
Title 10. Maryland Department of Health |
Part 4. |
Subtitle 34. BOARD OF PHARMACY |
Chapter 10.34.23. Pharmaceutical Services to Patients in Comprehensive Care Facilities |
Sec. 10.34.23.08. Labeling of Patient Medications
-
A. The director of pharmacy or designee shall ensure that medications dispensed by the pharmacy and intended for use within the comprehensive care facility are dispensed in appropriate containers and are labeled with the:
(1) Name and address of the pharmacy;
(2) Date of dispensing;
(3) Prescription number assigned by the pharmacy;
(4) Name of the patient;
(5) Name, quantity, and strength of the drug;
(6) Name of the prescriber;
(7) Expiration date of the drug;
(8) Required precautionary information regarding controlled substances; and
(9) Further cautionary information as may be required or desirable for proper use of the medication.
B. The director of pharmacy or designee shall ensure that medication provided per dosing period in a single container, slot, blister package, any other method of delivering an entire single dosing unit, or as part of a multi-dose dispensing package is labeled with at least the following:
(1) Drug name;
(2) Drug strength;
(3) Name of manufacturer;
(4) Name of the patient;
(5) Lot number; and
(6) Expiration date.
C. The director of pharmacy or designee shall be responsible for the safe and efficient dispensing, delivery, control of, and accountability for medications and devices dispensed or distributed by the permit holder.
D. The director of pharmacy or designee shall work in cooperation with the other professional staff of the comprehensive care facility in meeting the responsibilities set forth in §B of the regulation and in ordering, storing, and accounting for pharmaceutical materials.
E. Compounded Sterile Preparations. When compounding sterile preparations a licensed pharmacist or a registered pharmacy technician under the licensed pharmacists supervision, shall comply with the compounding and labeling requirements of COMAR 10.34.19.